Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results

r share

(0.70)Shares used to compute basic anddiluted net loss per share

86,04485,56085,84185,544 CADENCE PHARMACEUTICALS, INC.CONDENSED BALANCE SHEETS(in thousands)September 30,December 31,20132012(unaudited)AssetsCurrent assets:Cash, cash equivalents and short-term investments 

2,072Restricted cash 

548640Accounts receivable, net 


6,0946,498Prepaid expenses and other current assets 

1,3071,154Total current assets

70,96676,516Property and equipment, net

1,8011,967Intangible assets, net

11,08212,090Other assets

1757,106Total assets

97,679Liabilities and Stockholders' Equity Current liabilities:Accounts payable 

5,796Accrued liabilities 

15,37912,969Deferred revenue 

-2,234Current portion of long-term debt, less discount 

7,937-Total current liabilities

27,78920,999Other liabilities

60451Long-term debt, less discount

21,25128,818Total stockholders' equity

34,38047,811Total liabilities and stockholders' equity



SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
2. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
3. Cadence Pharmaceuticals Comments on USPTOs Non-Final, Initial Office Action on Reexamination of Patent
4. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
5. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
6. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
7. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
8. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
10. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
11. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
Post Your Comments:
(Date:10/8/2015)... 8, 2015 " Biomedical Refrigerators ... Trends and Forecast 2014 - 2022 " , the ... billion in 2013 and is anticipated to expand at a ... 4.00 billion in 2022. --> " Biomedical ... Growth, Trends and Forecast 2014 - 2022 " , ...
(Date:10/8/2015)... DUBLIN , Oct. 08 2015 /PRNewswire/ ... announced the addition of the "Natural ... Life Sciences Industry by Type (Rule-Based, Statistical, ... Europe, Asia-Pacific, Middle East and Africa, Latin ... report to their offering. --> ...
(Date:10/8/2015)... -- Celtaxsys, a clinical stage drug development company focused on ... announced today the commencement of the US arm of ... compound, acebilustat, in patients with cystic fibrosis (CF). The ... the United States and European ... early 2016. This landmark clinical trial testing once-daily oral ...
Breaking Medicine Technology:
... July 20, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... results for the second quarter 2011 prior to the open ... John H. Johnson, Chief Executive Officer and President, and ... host an investment community conference call beginning at 9:00 a.m. ...
... LOUISVILLE, Ky., July 20, 2011 BellaNovus Development ... today announced its launch of the Ouchless™ Needle ... an innovative alternative to numbing creams and ice ... cosmetic injectables, such as Botox® and dermal fillers. ...
Cached Medicine Technology:
(Date:10/9/2015)... , ... October 09, 2015 , ... ... upcoming episode of Innovations with Ed Begley Jr., airing 1st QT 2016 via ... will educate audiences on MMJ Phytotech Limited (MMJ) – a global leader in ...
(Date:10/9/2015)... Bethesda, Maryland (PRWEB) , ... October 09, 2015 ... ... care and assisted living placement counseling, recently opened its newest office in Maryland ... the senior care industry with a background as a project management technology consultant ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Kitchenistas of National ... diabetes, obesity, and other health conditions related to food, has been selected for viewing ... at the Global Health Film Festival on October 30-31 in London, England. , The ...
(Date:10/9/2015)... Abilene, Texas (PRWEB) , ... October 09, 2015 , ... ... new article this week that takes the subject of health care back to the ... too many sicknesses that are able to be prevented if only biblical laws were ...
(Date:10/8/2015)... ... October 09, 2015 , ... The Guthrie Sports Medicine/Twin Tiers ... support post-concussion group was started by Steven Hicks, a Licensed Athletic Trainer, with ... was started in November 2010 to help support student athletes, their ...
Breaking Medicine News(10 mins):
... may be related to trend toward less sleep, ... to the many reasons why people should get adequate sleep, ... insulin resistance, a component of type 2 diabetes. , The ... after a night of normal sleep (about eight hours) and ...
... In ... Trade to the table with Tampa Bay’s greenest coffee roasters. , ... Tampa, Fla. (PRWEB) May 6, 2010 -- Java Planet, ... and commitment to Fair Trade by gaining the certifications needed to be able to use ...
... anatomical alterations in children with genetic disorder , THURSDAY, May ... with fragile X syndrome differs from that in boys without ... X syndrome, which is triggered by a mutation in a ... inherited intellectual disability and autism. Though the syndrome affects ...
... is safe, improves blood sugar control , THURSDAY, May ... have been encapsulated have been successfully transplanted into humans ... cells. , What,s more, scientists report, the transplanted pig ... to high blood sugar levels in the blood, improving ...
... releases (embargo: 6 May, 16:45 CEST) , J. Hicks, ... cells from very small samples , Researchers have developed a ... cells. The breakthrough allows them to study in fine detail ... Estrogen receptor status of HER2+ breast cancer correlates with response ...
... Brussels, 6 May 2010 -- An international team of ... some women with HER2 over-expressing breast cancer do not ... The research, presented at the IMPAKT Breast Cancer ... on future clinical trial design and treatment strategies in ...
Cached Medicine News:
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
... profile endocardial permanent pacing leads with an ... size of only 4.8 F and a ... Physique lead is the smallest extendable/retractable bipolar ... straight and pre-formed J configurations, Physique leads ...
... The Vitatron Impulse II lead series ... designed to extend the longevity of ... efficient pacing. The high impedance of ... the small electrode surface, combined with ...
The CapSure Z Novus is an endocardial, tined, high-efficiency lead. High efficiency combined with steroid elution allows safe, low output programming....
Medicine Products: